US health tech firm Tempus AI plans to acquire cancer diagnostics firm Personalis
MLex Summary: Chicago-based Tempus AI, which creates personalized medicine tools, intends to pay $1.5 billion to take over Personalis, a cancer technology company based in Fremont, California.Jul 20, 2026 8:30 AM...To view the full article, register now.
Already a subscriber? Click here to view full article